(Q39107059)

9 September 2017

Inhibition of hepatic fibrosis with artificial microRNA using ultrasound and cationic liposome-bearing microbubbles (English)

1 reference

9 September 2017

1 reference

1 reference

D Yang

1

1 reference

9 September 2017

Y-H Gao

2

1 reference

9 September 2017

K-B Tan

3

1 reference

9 September 2017

Z-X Zuo

4

1 reference

9 September 2017

W-X Yang

5

1 reference

9 September 2017

X Hua

6

1 reference

9 September 2017

P-J Li

7

1 reference

9 September 2017

Y Zhang

8

1 reference

9 September 2017

G Wang

9

1 reference

9 September 2017

22 August 2013

1 reference

9 September 2017

1 reference

9 September 2017

20

1 reference

9 September 2017

12

1 reference

9 September 2017

1140-1148

1 reference

https://scigraph.springernature.com/pub.10.1038/gt.2013.41

9 September 2017

0 references

cites work

Pathogenesis of liver fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.41

Mechanisms of hepatic fibrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.41

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.41

TGF-beta1 gene silencing for treating liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.41

Connective tissue growth factor hammerhead ribozyme attenuates human hepatic stellate cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.41

Regulation of hepatic stellate cells by connective tissue growth factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.41

RNA interfering connective tissue growth factor prevents rat hepatic stellate cell activation and extracellular matrix production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.41

The clinical value of serum connective tissue growth factor in the assessment of liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.41

siRNA-mediated knockdown of connective tissue growth factor prevents N-nitrosodimethylamine-induced hepatic fibrosis in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.41

Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.41

Construction of an artificial MicroRNA expression vector for simultaneous inhibition of multiple genes in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.41

Artificial microRNA-based neurokinin-1 receptor gene silencing reduces alcohol consumption in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.41

Artificial microRNA interference targeting AT(1a) receptors in paraventricular nucleus attenuates hypertension in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.41

Progress in the development of ultrasound-mediated gene delivery systems utilizing nano- and microbubbles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.41

Ultrasound-targeted microbubble destruction can repeatedly direct highly specific plasmid expression to the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.41

Acoustically-active microbubbles conjugated to liposomes: characterization of a proposed drug delivery vehicle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.41

Ultrasound assisted siRNA delivery using PEG-siPlex loaded microbubbles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.41

Effects of diagnostic ultrasound-targeted microbubble destruction on permeability of normal liver in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.41

Immune responses to AAV in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.41

RNA interference targeting the platelet-derived growth factor receptor beta subunit ameliorates experimental hepatic fibrosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.41

Hydrodynamic gene delivery to the liver: theoretical and practical issues for clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.41

Gene therapy of carcinoma using ultrasound-targeted microbubble destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.41

Myocardial injury induced by ultrasound-targeted microbubble destruction: evidence for the contribution of myocardial ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.41

Ultrasound-targeted microbubble destruction enhances naked plasmid DNA transfection in rabbit Achilles tendons in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.41

Myocardium-targeted transplantation of mesenchymal stem cells by diagnostic ultrasound-mediated microbubble destruction improves cardiac function in myocardial infarction of New Zealand rabbits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.41

Vascular effects of microbubble-enhanced, pulsed, focused ultrasound on liver blood perfusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.41

Gene delivery by lipoplexes and polyplexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.41

Resveratrol inhibits dimethylnitrosamine-induced hepatic fibrosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.41

Fibrosis and cirrhosis reversibility - molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.41

Reversal of liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.41

Morphological and serum hyaluronic acid, laminin and type IV collagen changes in dimethylnitrosamine-induced hepatic fibrosis of rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.41

Antisense inhibition of connective tissue growth factor (CTGF/CCN2) mRNA limits hypertrophic scarring without affecting wound healing in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.41

7 January 2021

Inhibition of connective tissue growth factor by siRNA prevents liver fibrosis in rats

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.41

7 January 2021

Ultrasound targeted microbubble destruction for drug and gene delivery

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.41

7 January 2021

Effects of a novel ultrasound contrast agent with long persistence on right ventricular pressure: Comparison with SonoVue

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.41

7 January 2021

Molecular imaging of vulnerable plaques in rabbits using contrast-enhanced ultrasound targeting to vascular endothelial growth factor receptor-2

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.41

7 January 2021

Development and evaluation of lipid microbubbles targeted to alpha(v)beta(3)-integrin via biotin-avidin bridge

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.41

7 January 2021

Identifiers

DOI

10.1038/GT.2013.41

1 reference

9 September 2017

1 reference